TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Primex Pharmaceuticals Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
647
|
5,138
|
1,331 |
Financial expenses |
372
|
28
|
75 |
Earnings before taxes |
-1,108
|
630
|
-419 |
Total assets |
12,414
|
6,676
|
4,399 |
Current assets |
2,852
|
2,555
|
677 |
Current liabilities |
388
|
1,042
|
566 |
Equity capital |
7,026
|
5,634
|
3,834 |
- share capital |
3
![]() |
3
![]() |
3 |
Employees (average) | 6 | 6 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
56.6%
|
84.4%
|
87.2% |
Turnover per employee | 108 | 222 | |
Profit as a percentage of turnover |
-171.3%
|
12.3%
|
-31.5% |
Return on assets (ROA) |
-5.9%
|
9.9%
|
-7.8% |
Current ratio |
735.1%
|
245.2%
|
119.6% |
Return on equity (ROE) |
-15.8%
|
11.2%
|
-10.9% |
Change turnover |
-4,491
|
3,807
|
745 |
Change turnover % |
-87%
|
286%
|
127% |
Chg. No. of employees | 1 | ||
Chg. No. of employees % | 20% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.